These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3401033)

  • 1. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans.
    Henderson CD; Tschen JA; Schaefer DG
    Arch Dermatol; 1988 Aug; 124(8):1258-60. PubMed ID: 3401033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythema dyschromicum perstans and vitiligo.
    Naik NS
    Dermatol Online J; 2003 Oct; 9(4):25. PubMed ID: 14594598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythema cinitiensis perstans].
    Sittart JA; Tayah M
    Med Cutan Ibero Lat Am; 1980; 8(1-3):11-4. PubMed ID: 7022047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of erythema dyschromicum perstans and vitiligo: a case report and review of the literature.
    Tamer F
    Acta Dermatovenerol Alp Pannonica Adriat; 2016 Dec; 25(4):77-78. PubMed ID: 28006880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema dyschromicum perstans and lichen planus.
    Naidorf KF; Cohen SR
    Arch Dermatol; 1982 Sep; 118(9):683-5. PubMed ID: 7114873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythema dyschromicum perstans].
    Möller-Vietheer M; Goos M
    Hautarzt; 1977 Oct; 28(10):539-41. PubMed ID: 340421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural pathology of erythema dyschromicum perstans.
    Soter NA; Wand C; Freeman RG
    J Invest Dermatol; 1969 Feb; 52(2):155-62. PubMed ID: 5774894
    [No Abstract]   [Full Text] [Related]  

  • 8. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
    Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
    Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema dyschromicum perstans: a case report and review.
    Osswald SS; Proffer LH; Sartori CR
    Cutis; 2001 Jul; 68(1):25-8. PubMed ID: 11480143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythema dischromicum perstans (ashy dermatosis). Report of two cases].
    Paradisi M; Mostaccioli S; Celano G; Angelo C; Ruatti P; Ferranti G; Onetti Muda A; Faraggiana T
    Pathologica; 1993; 85(1099):533-41. PubMed ID: 8127636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periorbital hyperpigmentation and erythema dyschromicum perstans.
    Ing EB; Buncic JR; Weiser BA; de Nanassy J; Boxall L
    Can J Ophthalmol; 1992 Dec; 27(7):353-5. PubMed ID: 1490247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema dyschromicum perstans and hepatitis C virus infection.
    Kontochristopoulos GJ; Aroni K; Anagnostopoulos G; Nakopoulou L; Tassopoulos NC
    Int J Dermatol; 2001 May; 40(5):346-8. PubMed ID: 11555000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erythema dyschromicum perstans (ashy dermatosis)].
    David M; Sandbank M; Feuerman EJ
    Harefuah; 1978 Oct; 95(8):258-9. PubMed ID: 744526
    [No Abstract]   [Full Text] [Related]  

  • 14. [Macular idiopathic pigmentation (erythema dyschromicum perstans)].
    Karalitskiĭ EM; Khmelevskiĭ AD
    Vestn Dermatol Venerol; 1984 Feb; (2):49-51. PubMed ID: 6720074
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
    Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
    J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy.
    Baranda L; Torres-Alvarez B; Cortes-Franco R; Moncada B; Portales-Perez DP; Gonzalez-Amaro R
    Arch Dermatol; 1997 Mar; 133(3):325-9. PubMed ID: 9080892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema dyschromicum perstans in phototype II women: three unusual clinical cases studied with electron microscopy.
    Persechino S; Caperchi C; Cortesi G; Persechino F; Raffa S; Pulcini F; Tammaro A; Torrisi MR
    Eur J Dermatol; 2011; 21(2):261-2. PubMed ID: 21382781
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic toxic erythemo-macular skin hyperpigmentation (erythema dyschromicum perstans, ashy dermatosis].
    Samos-Zielińska J; Lańcucki J; Dabrowski J; Sadowska-Iwańciow H
    Przegl Dermatol; 1979; 66(4):385-91. PubMed ID: 493562
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythema dyschromicum perstans in an HIV antibody-positive man.
    Nelson MR; Lawrence AG; Staughton RC; Gazzard BG
    Br J Dermatol; 1992 Dec; 127(6):658-9. PubMed ID: 1476930
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis).
    Vásquez-Ochoa LA; Isaza-Guzmán DM; Orozco-Mora B; Restrepo-Molina R; Trujillo-Perez J; Tapia FJ
    Int J Dermatol; 2006 Aug; 45(8):937-41. PubMed ID: 16911378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.